Kenneth Frazier

Mr. Kenneth C.
Frazier is a Chairman at Transcarent, Inc., an Independent Director at Eikon Therapeutics, Inc., a Chairman of Health Assurance Initiatives at General Catalyst LLC, a Chairman at MSD Pharma (Singapore) Pte Ltd., a Co-Chairman at Oneten, a Co-Chairman-Leaders Council of Legal Services Corp., a Council Member at American Bar Association, a Council Member at The American Law Institute, a Member at American Academy of Arts & Sciences, a Member at American Philosophical Society, a Member at Council on Foreign Relations, Inc., a Member of President's Export Council and a Member at The Business Council.
He is on the Board of Directors at Eikon Therapeutics, Inc., Catalyst, Inc., Cornerstone Christian Academy, Merck Sharp & Dohme Corp., National Constitution Center, Paradigm Health, Inc., Pharmaceutical Research & Manufacturers of America, Weill Cornell Medicine and The Pennsylvania State University.
Mr. Frazier was previously employed as a Lead Independent Director by Exxonmobil Corp., a Secretary, Vice President & General Counsel by Astra Merck, Inc., an Executive Chairman by Merck & Co., Inc., and a Partner by Drinker Biddle & Reath LLP.
He received his undergraduate degree from The Pennsylvania State University and a graduate degree from Harvard Law School.